Community-Onset Bloodstream Infections Diagnosis Market Research Report – Segmentation by Component (Instruments, Consumables, Software, Services, and Other Components); Application (Bacterial, Fungal, Mycobacterial); End-User (Hospitals, Diagnostic Centers, Research Institutes, and Others); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030
Published: 2024 - January
Report Code: IM-14985
Format:
Region: Global
Chapter 1. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – By Component
6.1. Instruments
6.2. Consumable
6.3. Software
6.4. Services
6.5. Other Components
Chapter 7. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – By Application
7.1. Bacterial
7.2. Fungal
7.3. Mycobacterial
Chapter 8. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – By End User
8.1. Hospitals
8.2. Diagnostic Centers
8.3. Research Institutes
8.4. Others
Chapter 9. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – By Region
9.1. North America
9.2. Europe
9.3. Asia-P2acific
9.4. Latin America
9.5. The Middle East
9.6. Africa
Chapter 10. COMMUNITY-ONSET BLOODSTREAM INFECTIONS DIAGNOSIS MARKET – By Companies
10.1. Companies 1
10.2. Companies 2
10.3. Companies 3
10.4. Companies 4
10.5. Companies 5
10.6. Companies 6
10.7. Companies 7
10.8. Companies 8
10.9. Companies 9
10.10. Companies 10
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Global Community-Onset Bloodstream Infections Diagnosis Market was estimated to be worth USD 4.98 Billion in 2023 and is projected to reach a value of USD 7.19 Billion by 2030, growing at a fast compound annual growth rate (CAGR) of 4.7% during the forecast period 2023-2030.
The Global Community-Onset Bloodstream Infections Diagnosis Market is driven by the Increasing prevalence of CO-BSIs, Technological advancements in diagnostic tools, Rising demand for early diagnosis and treatment, and increasing healthcare expenditure.
The Segments under the Global Community-Onset Bloodstream Infections Diagnosis Market by the application are Bacterial, Fungal, and Mycobacterial.
China, Japan, South Korea, Singapore, and India are the most dominating countries in the Asia Pacific region for the Global Community-Onset Bloodstream Infections Diagnosis Market.
BD (Becton, Dickinson and Company), bioMérieux SA, Thermo Fisher Scientific Inc. are the three major leading players in the Global Community-Onset Bloodstream Infections Diagnosis Market.
